2014
DOI: 10.5935/medicalexpress.2014.03.03
|View full text |Cite
|
Sign up to set email alerts
|

Clinical pharmacology of analgesics in infants and the pharmacologic management of pain in neonates

Abstract: The objectives of this study are to describe (1) the clinical pharmacology of analgesics in infants and (2) the pharmacologic management of pain in neonates. METHODS: The bibliographic search was performed using PubMed and EMBASE databases as search engines. RESULTS: Opioid analgesics are the most commonly used analgesics for acute pain and they include intravenous morphine (50 to 200 mg/kg), oral methadone (50 to 200 mg/kg), intravenous fentanyl (0.5 to 4 mg/kg), alfentanyl (10 to 20 mg/kg), sufentanil (10 to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 113 publications
0
4
0
Order By: Relevance
“…Mechanically ventilated neonates (>24 hours) also had significantly higher morphine plasma concentrations. The control of pain by analgesics other than morphine has been recently reviewed elsewhere 17-19.…”
Section: Resultsmentioning
confidence: 99%
“…Mechanically ventilated neonates (>24 hours) also had significantly higher morphine plasma concentrations. The control of pain by analgesics other than morphine has been recently reviewed elsewhere 17-19.…”
Section: Resultsmentioning
confidence: 99%
“…However, the elimination half-life does not change with age, with its average value being between 3.4 and 5.7 minutes, demonstrating rapid clearance similar to adults. [15][16][17][18] The increased volume of distribution is due to the higher percentage of total body water and higher circulating volume in the pediatric age. The increased clearance may be explained by the fact that neonates and infants have a more remarkable ability to metabolize drugs due to their relatively large liver size or increased hepatic blood flow.…”
Section: Pediatric Patientsmentioning
confidence: 99%
“…However, these same properties are responsible either for bioaccumulation and toxic effects in aquatic and terrestrial ecosystems (Santos 487 et al, 2010). GAB is eliminated from the systemic circulation by renal excretion (FDA, 2011), and intestinal excretion (Prasad, 2019) as unchanged drug and is not appreciably metabolized in humans (FDA, 2011), a quarter of the administered dose of PB is excreted unchanged in the urine in neonates and adults (Pacifici, 2014), and intestinal excretion (Yumiko et al, 2019), 2% of OX is excreted unchanged by the body, as well as carbamazepine and intestinal excretion (Bahlmann et al, 2014).…”
mentioning
confidence: 99%